Evidence map›Paper›PMID 33799972›Full record

ArticleCancers2021

Long-Term Outcomes of Stereotactic Radiosurgery for Trigeminal, Facial, and Jugular Foramen Schwannoma in Comparison with Vestibular Schwannoma.

Yuki Shinya, Hirotaka Hasegawa, Masahiro Shin, Takehiro Sugiyama, Mariko Kawashima, Atsuto Katano, Akinori Kashio, Kenji Kondo, Nobuhito Saito

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Yuki ShinyaDepartment of Neurosurgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan.ORCID 0000-0003-0097-5804
Hirotaka HasegawaDepartment of Neurosurgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan.ORCID 0000-0002-3585-2188
Masahiro ShinDepartment of Neurosurgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan.ORCID 0000-0001-8025-127X
Takehiro SugiyamaDiabetes and Metabolism Information Center, Research Institute, National Center for Global Health and Medicine, Tokyo 162-8655, Japan.ORCID 0000-0001-5391-682X
Mariko KawashimaDepartment of Neurosurgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Atsuto KatanoDepartment of Radiology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Akinori KashioDepartment of Otorhinolaryngology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Kenji KondoDepartment of Otorhinolaryngology, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
Nobuhito SaitoDepartment of Neurosurgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
University of Tokyo Hospital · JPUniversity of Tsukuba · JP

Funding

SPS KAKENHI 19K24042
6 · The paper itself

Abstract

Stereotactic radiosurgery (SRS) is known to provide excellent tumor control with functional preservation for vestibular schwannomas (VS), but its efficacy in the other major intracranial schwannomas including trigeminal (TS), facial (FS), and jugular foramen schwannomas (JFS) has not been established yet due to their rarity. We retrospectively analyzed data of 514 consecutive patients who had intracranial schwannomas (460 VS, 22 TS, 7 FS, and 25 JFS) and underwent SRS. The 5- and 10-year tumor control rates were 97% and 94% for VS, 100% and 100% for TS, 80% and 80% for FS, and 100% and 80% for JFS. Radiation-induced complications included one hydrocephalus for TS (4.5%), no cases for FS (0%), and one hydrocephalus and one lower palsy for JFS (8.0%). Through matched cohort analysis between patients with VS and each of the non-VS, we found no statistical difference in tumor control and radiation-induced adverse events. SRS seems to provide long-term tumor control with functional preservation for TS, FS and JFS and the efficacies are similar to VS.

Indexed as

intracranial schwannomaslong-term outcomesmatched cohort analysesstereotactic radiosurgery

Identifiers

PMID33799972
PMCPMC7961475
OpenAlexW3134855915

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.